.png)
Gastrointestinal Therapeutics Market by Route and Application - Global Industry Analysis & Forecast to 2027
Published On : June 2022 Pages : 149 Category: Pharma & Healthcare Report Code : HC064151
SEGMENTS & REGIONS:
- Regions: North America, Europe, Asia- Pacific, Latin America, Middle East & Africa
Gastrointestinal Therapeutics Market by Route (Oral, Intravenous, Others) Application (Ulcerative Colitis, Crohn’s Disease, GERD, Other Application) - Global Industry Analysis & Forecast to 2027
Industry Outlook and Trend Analysis
Gastrointestinal Therapeutics are utilized for their impacts on the gastrointestinal system, for example, improving processing, direct versatility and water stream so as to manage the gastrointestinal framework, and controlling gastric acidity. Gastrointestinal tract otherwise called the stomach related tract is an organ system present inside creature and people that take nourishment and work on its absorption system.
Drivers and Restraints
Developing predominance of gastrointestinal infections among people is a key factor driving the development of the worldwide gastrointestinal therapeutics market. What's more, expanding appropriation of the biologic medication for the treatment of gastrointestinal illnesses is another factor supporting the development of the worldwide market. Moreover, developing mindfulness with respect to gastrointestinal medications and extending the openness of treatment are likewise factors expected to help the development of the worldwide gastrointestinal therapeutics market sooner rather than later.
Regional Insights
The market in North America accounted for a major share in terms of revenue and is expected to maintain its dominance over the forecast period.
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Russia
- Italy
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Southeast Asia
- Rest of Asia-Pacific
- South America
- Brazil
- Argentina
- Columbia
- Rest of South America
- Middle East and Africa
- Saudi Arabia
- UAE
- Egypt
- Nigeria
- South Africa
- Rest of MEA
Competitive Analysis
The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and share of the overall industry.
- Allergan plc
- Boehringer Ingelheim GmbH
- AstraZeneca PLC
- Valeant Pharmaceuticals International company
- Abbott Laboratories
- Takeda Pharmaceutical Company Limited
- Janssen Biotech, Inc.
- Sanofi company
- Bayer AG
- GlaxoSmithKline plc
Some of the key questions answered by the report are:
- What was the market size in 2017 and forecast from 2017 to 2027?
- What will be the industry market growth from 2017 to 2027?
- What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
- What are the major segments leading the market growth and why?
- Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?
Market Classification
· Gastrointestinal Therapeutics Market, By Route, Estimates and Forecast, 2017-2027 ($Million)
o Oral
o Intravenous
o Others
· Gastrointestinal Therapeutics Market, By Application, Estimates and Forecast, 2017-2027 ($Million)
o Ulcerative Colitis
o Crohn’s Disease
o GERD
o Other Application
· Gastrointestinal Therapeutics Market, By Key Players
o Allergan plc
o Boehringer Ingelheim GmbH
o AstraZeneca PLC
o Valeant Pharmaceuticals International company
o Abbott Laboratories
o Takeda Pharmaceutical Company Limited
o Janssen Biotech, Inc.
o Sanofi company
o Bayer AG
o GlaxoSmithKline plc
· Gastrointestinal Therapeutics Market, By Region, Estimates and Forecast, 2017-2027 ($Million)
o North America
§ North America Gastrointestinal Therapeutics Market, By Country
o U.S. Gastrointestinal Therapeutics Market
o Canada Gastrointestinal Therapeutics Market
o Mexico Gastrointestinal Therapeutics Market
o Europe
§ Europe Gastrointestinal Therapeutics Market, By Country
o Germany Gastrointestinal Therapeutics Market
o UK Gastrointestinal Therapeutics Market
o France Gastrointestinal Therapeutics Market
o Russia Gastrointestinal Therapeutics Market
o Italy Gastrointestinal Therapeutics Market
o Rest of Europe Gastrointestinal Therapeutics Market
o Asia-Pacific
§ Asia-Pacific Gastrointestinal Therapeutics Market, By Country
o China Gastrointestinal Therapeutics Market
o Japan Gastrointestinal Therapeutics Market
o South Korea Gastrointestinal Therapeutics Market
o India Gastrointestinal Therapeutics Market
o Southeast Asia Gastrointestinal Therapeutics Market
o Rest of Asia-Pacific Gastrointestinal Therapeutics Market
o South America
§ South America Gastrointestinal Therapeutics Market
o Brazil Gastrointestinal Therapeutics Market
o Argentina Gastrointestinal Therapeutics Market
o Columbia Gastrointestinal Therapeutics Market
o Rest of South America Gastrointestinal Therapeutics Market
o Middle East and Africa
§ Middle East and Africa Gastrointestinal Therapeutics Market
o Saudi Arabia Gastrointestinal Therapeutics Market
o UAE Gastrointestinal Therapeutics Market
o Egypt Gastrointestinal Therapeutics Market
o Nigeria Gastrointestinal Therapeutics Market
o South Africa Gastrointestinal Therapeutics Market
o Rest of MEA Gastrointestinal Therapeutics Market
Table of Contents:
1. Introduction
1.1. Report Description
2. Executive Summary
2.1. Key Highlights
3. Market Overview
3.1. Introduction
3.1.1. Market Definition
3.1.2. Market Segmentation
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
4. Market Analysis by Regions
4.1. North America (United States, Canada and Mexico)
4.1.1. United States Market Status and Outlook (2017-2027)
4.1.2. Canada Market Status and Outlook (2017-2027)
4.1.3. Mexico Market Status and Outlook (2017-2027)
4.2. Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
4.2.1. Germany Market Status and Outlook (2017-2027)
4.2.2. France Market Status and Outlook (2017-2027)
4.2.3. UK Market Status and Outlook (2017-2027)
4.2.4. Russia Market Status and Outlook (2017-2027)
4.2.5. Italy Market Status and Outlook (2017-2027)
4.2.6. Rest of Europe Market Status and Outlook (2017-2027)
4.3. Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Rest of Asia-Pacific)
4.3.1. China Market Status and Outlook (2017-2027)
4.3.2. Japan Market Status and Outlook (2017-2027)
4.3.3. Korea Market Status and Outlook (2017-2027)
4.3.4. India Market Status and Outlook (2017-2027)
4.3.5. Southeast Asia Market Status and Outlook (2017-2027)
4.3.6. Rest of Asia-Pacific Market Status and Outlook (2017-2027)
4.4. South America (Brazil, Argentina, Columbia and Rest of South America)
4.4.1. Brazil Market Status and Outlook (2017-2027)
4.4.2. Argentina Market Status and Outlook (2017-2027)
4.4.3. Columbia Market Status and Outlook (2017-2027)
4.4.4. Rest of South America Market Status and Outlook (2017-2027)
4.5. Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of MEA)
4.5.1. Saudi Arabia Market Status and Outlook (2017-2027)
4.5.2. United Arab Emirates Market Status and Outlook (2017-2027)
4.5.3. Egypt Market Status and Outlook (2017-2027)
4.5.4. Nigeria Market Status and Outlook (2017-2027)
4.5.5. South Africa Market Status and Outlook (2017-2027)
4.5.6. Turkey Market Status and Outlook (2017-2027)
4.5.7. Rest of Middle East and Africa Market Status and Outlook (2017-2027)
5. Gastrointestinal Therapeutics Market, By Route
5.1. Introduction
5.2. Global Gastrointestinal Therapeutics Revenue and Market Share by Route (2017-2027)
5.2.1. Global Gastrointestinal Therapeutics Revenue and Revenue Share by Route (2017-2027)
5.3. Oral
5.3.1. Global Oral Revenue and Growth Rate (2017-2027)
5.4. Intravenous
5.4.1. Global Intravenous Revenue and Growth Rate (2017-2027)
5.5. Others
5.5.1. Global Others Revenue and Growth Rate (2017-2027)
6. Gastrointestinal Therapeutics Market, By Application
6.1. Introduction
6.2. Global Gastrointestinal Therapeutics Revenue and Market Share by Application (2017-2027)
6.2.1. Global Gastrointestinal Therapeutics Revenue and Revenue Share by Application (2017-2027)
6.3. Ulcerative Colitis
6.3.1. Global Ulcerative Colitis Revenue and Growth Rate (2017-2027)
6.4. Crohn’s Disease
6.4.1. Global Crohn’s Disease Revenue and Growth Rate (2017-2027)
6.5. GERD
6.5.1. Global GERD Revenue and Growth Rate (2017-2027)
6.6. Other Application
6.6.1. Global Other Application Revenue and Growth Rate (2017-2027)
7. Gastrointestinal Therapeutics Market, By Region
7.1. Introduction
7.2. Global Gastrointestinal Therapeutics Revenue and Market Share by Regions
7.2.1. Global Gastrointestinal Therapeutics Revenue by Regions (2017-2027)
7.3. North America Gastrointestinal Therapeutics by Countries
7.3.1. North America Gastrointestinal Therapeutics Revenue and Growth Rate (2017-2027)
7.3.2. North America Gastrointestinal Therapeutics Revenue (Million USD) by Countries (2017-2027)
7.3.3. United States
7.3.3.1. United States Gastrointestinal Therapeutics Revenue (Millions USD) and Growth Rate (2017-2027)
7.3.4. Canada
7.3.4.1. Canada Gastrointestinal Therapeutics Revenue (Millions USD) and Growth Rate (2017-2027)
7.3.5. Mexico
7.3.5.1. Mexico Gastrointestinal Therapeutics Revenue (Millions USD) and Growth Rate (2017-2027)
7.4. Europe Gastrointestinal Therapeutics by Countries
7.4.1. Europe Gastrointestinal Therapeutics Revenue and Growth Rate (2017-2027)
7.4.2. Europe Gastrointestinal Therapeutics Revenue (Million USD) by Countries (2017-2027)
7.4.3. Germany
7.4.3.1. Germany Gastrointestinal Therapeutics Revenue (Millions USD) and Growth Rate (2017-2027)
7.4.4. France
7.4.4.1. France Gastrointestinal Therapeutics Revenue (Millions USD) and Growth Rate (2017-2027)
7.4.5. UK
7.4.5.1. UK Gastrointestinal Therapeutics Revenue (Millions USD) and Growth Rate (2017-2027)
7.4.6. Russia
7.4.6.1. Russia Gastrointestinal Therapeutics Revenue (Millions USD) and Growth Rate (2017-2027)
7.4.7. Italy
7.4.7.1. Italy Gastrointestinal Therapeutics Revenue (Millions USD) and Growth Rate (2017-2027)
7.4.8. Rest of Europe
7.4.8.1. Rest of Europe Gastrointestinal Therapeutics Revenue (Millions USD) and Growth Rate (2017-2027)
7.5. Asia-Pacific Gastrointestinal Therapeutics by Countries
7.5.1. Asia-Pacific Gastrointestinal Therapeutics Revenue and Growth Rate (2017-2027)
7.5.2. Asia-Pacific Gastrointestinal Therapeutics Revenue (Million USD) by Countries (2017-2027)
7.5.3. China
7.5.3.1. China Gastrointestinal Therapeutics Revenue (Millions USD) and Growth Rate (2017-2027)
7.5.4. Japan
7.5.4.1. Japan Gastrointestinal Therapeutics Revenue (Millions USD) and Growth Rate (2017-2027)
7.5.5. Korea
7.5.5.1. Korea Gastrointestinal Therapeutics Revenue (Millions USD) and Growth Rate (2017-2027)
7.5.6. India
7.5.6.1. India Gastrointestinal Therapeutics Revenue (Millions USD) and Growth Rate (2017-2027)
7.5.7. Southeast Asia
7.5.7.1. Southeast Asia Gastrointestinal Therapeutics Revenue (Millions USD) and Growth Rate (2017-2027)
7.5.8. Rest of Asia-Pacific
7.5.8.1. Rest of Asia-Pacific Gastrointestinal Therapeutics Revenue (Millions USD) and Growth Rate (2017-2027)
7.6. South America Gastrointestinal Therapeutics by Countries
7.6.1. South America Gastrointestinal Therapeutics Revenue and Growth Rate (2017-2027)
7.6.2. South America Gastrointestinal Therapeutics Revenue (Million USD) by Countries (2017-2027)
7.6.3. Brazil
7.6.3.1. Brazil Gastrointestinal Therapeutics Revenue (Millions USD) and Growth Rate (2017-2027)
7.6.4. Argentina
7.6.4.1. Argentina Gastrointestinal Therapeutics Revenue (Millions USD) and Growth Rate (2017-2027)
7.6.5. Columbia
7.6.5.1. Columbia Gastrointestinal Therapeutics Revenue (Millions USD) and Growth Rate (2017-2027)
7.6.6. Rest of South America
7.6.6.1. Rest of South America Gastrointestinal Therapeutics Revenue (Millions USD) and Growth Rate (2017-2027)
7.7. Middle East and Africa Gastrointestinal Therapeutics by Countries
7.7.1. Middle East and Africa Gastrointestinal Therapeutics Revenue and Growth Rate (2017-2027)
7.7.2. Middle East and Africa Gastrointestinal Therapeutics Revenue (Million USD) by Countries (2017-2027)
7.7.3. Saudi Arabia
7.7.3.1. Saudi Arabia Gastrointestinal Therapeutics Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.4. United Arab Emirates
7.7.4.1. United Arab Emirates Gastrointestinal Therapeutics Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.5. Egypt
7.7.5.1. Egypt Gastrointestinal Therapeutics Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.6. Nigeria
7.7.6.1. Nigeria Gastrointestinal Therapeutics Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.7. South Africa
7.7.7.1. South Africa Gastrointestinal Therapeutics Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.8. Turkey
7.7.8.1. Turkey Gastrointestinal Therapeutics Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.9. Rest of Middle East and Africa
7.7.9.1. Rest of Middle East and Africa Gastrointestinal Therapeutics Revenue (Millions USD) and Growth Rate (2017-2027)
8. Company Profiles
8.1. Allergan plc
8.1.1. Business Overview
8.1.2. Service Portfolio
8.1.3. Strategic Developments
8.1.4. Financial Overview
8.2. Boehringer Ingelheim GmbH
8.2.1. Business Overview
8.2.2. Service Portfolio
8.2.3. Strategic Developments
8.2.4. Financial Overview
8.3. AstraZeneca PLC
8.3.1. Business Overview
8.3.2. Service Portfolio
8.3.3. Strategic Developments
8.3.4. Financial Overview
8.4. Valeant Pharmaceuticals International company
8.4.1. Business Overview
8.4.2. Service Portfolio
8.4.3. Strategic Developments
8.4.4. Financial Overview
8.5. Abbott Laboratories
8.5.1. Business Overview
8.5.2. Service Portfolio
8.5.3. Strategic Developments
8.5.4. Financial Overview
8.6. Takeda Pharmaceutical Company Limited
8.6.1. Business Overview
8.6.2. Service Portfolio
8.6.3. Strategic Developments
8.6.4. Financial Overview
8.7. Janssen Biotech, Inc.
8.7.1. Business Overview
8.7.2. Service Portfolio
8.7.3. Strategic Developments
8.7.4. Financial Overview
8.8. Sanofi company
8.8.1. Business Overview
8.8.2. Service Portfolio
8.8.3. Strategic Developments
8.8.4. Financial Overview
8.9. Bayer AG
8.9.1. Business Overview
8.9.2. Service Portfolio
8.9.3. Strategic Developments
8.9.4. Financial Overview
8.10. GlaxoSmithKline plc
8.10.1. Business Overview
8.10.2. Service Portfolio
8.10.3. Strategic Developments
8.10.4. Financial Overview
9. Gastrointestinal Therapeutics Market Forecast (2017-2027)
9.1. Global Gastrointestinal Therapeutics Revenue (Millions USD) and Growth Rate (2017-2027)
9.2. Gastrointestinal Therapeutics Market Forecast by Regions (2017-2027)
9.2.1. North America Gastrointestinal Therapeutics Market Forecast (2017-2027)
9.2.1.1. United States Gastrointestinal Therapeutics Market Forecast (2017-2027)
9.2.1.2. Canada Gastrointestinal Therapeutics Market Forecast (2017-2027)
9.2.1.3. Mexico Gastrointestinal Therapeutics Market Forecast (2017-2027)
9.2.2. Europe Gastrointestinal Therapeutics Market Forecast (2017-2027)
9.2.2.1. Germany Gastrointestinal Therapeutics Market Forecast (2017-2027)
9.2.2.2. France Gastrointestinal Therapeutics Market Forecast (2017-2027)
9.2.2.3. UK Gastrointestinal Therapeutics Market Forecast (2017-2027)
9.2.2.4. Russia Gastrointestinal Therapeutics Market Forecast (2017-2027)
9.2.2.5. Italy Gastrointestinal Therapeutics Market Forecast (2017-2027)
9.2.2.6. Rest of Europe Gastrointestinal Therapeutics Market Forecast (2017-2027)
9.2.3. Asia-Pacific Gastrointestinal Therapeutics Market Forecast (2017-2027)
9.2.3.1. China Gastrointestinal Therapeutics Market Forecast (2017-2027)
9.2.3.2. Japan Gastrointestinal Therapeutics Market Forecast (2017-2027)
9.2.3.3. Korea Gastrointestinal Therapeutics Market Forecast (2017-2027)
9.2.3.4. India Gastrointestinal Therapeutics Market Forecast (2017-2027)
9.2.3.5. Southeast Asia Gastrointestinal Therapeutics Market Forecast (2017-2027)
9.2.3.6. Rest of Asia-Pacific Gastrointestinal Therapeutics Market Forecast (2017-2027)
9.2.4. South America Gastrointestinal Therapeutics Market Forecast (2017-2027)
9.2.4.1. Brazil Gastrointestinal Therapeutics Market Forecast (2017-2027)
9.2.4.2. Argentina Gastrointestinal Therapeutics Market Forecast (2017-2027)
9.2.4.3. Columbia Gastrointestinal Therapeutics Market Forecast (2017-2027)
9.2.4.4. Rest of South America Gastrointestinal Therapeutics Market Forecast (2017-2027)
9.2.5. Middle East and Africa Gastrointestinal Therapeutics Market Forecast (2017-2027)
9.2.5.1. Saudi Arabia Gastrointestinal Therapeutics Market Forecast (2017-2027)
9.2.5.2. United Arab Emirates Gastrointestinal Therapeutics Market Forecast (2017-2027)
9.2.5.3. Egypt Gastrointestinal Therapeutics Market Forecast (2017-2027)
9.2.5.4. Nigeria Gastrointestinal Therapeutics Market Forecast (2017-2027)
9.2.5.5. South Africa Gastrointestinal Therapeutics Market Forecast (2017-2027)
9.2.5.6. Turkey Gastrointestinal Therapeutics Market Forecast (2017-2027)
9.2.5.7. Rest of Middle East and Africa Gastrointestinal Therapeutics Market Forecast (2017-2027)
9.3. Gastrointestinal Therapeutics Market Forecast by Route (2017-2027)
9.3.1. Gastrointestinal Therapeutics Forecast by Route (2017-2027)
9.3.2. Gastrointestinal Therapeutics Market Share Forecast by Route (2017-2027)
9.4. Gastrointestinal Therapeutics Market Forecast by Application (2017-2027)
9.4.1. Gastrointestinal Therapeutics Forecast by Application (2017-2027)
9.4.2. Gastrointestinal Therapeutics Market Share Forecast by Application (2017-2027)
List of Tables
List of Tables and Figures:
Figure United States Gastrointestinal Therapeutics Revenue (Million USD) and Growth Rate (2017-2025)
Figure Canada Gastrointestinal Therapeutics Revenue (Million USD) and Growth Rate (2017-2025)
Figure Mexico Gastrointestinal Therapeutics Revenue (Million USD) and Growth Rate (2017-2025)
Figure Germany Gastrointestinal Therapeutics Revenue (Million USD) and Growth Rate (2017-2025)
Figure France Gastrointestinal Therapeutics Revenue (Million USD) and Growth Rate (2017-2025)
Figure UK Gastrointestinal Therapeutics Revenue (Million USD) and Growth Rate (2017-2025)
Figure Russia Gastrointestinal Therapeutics Revenue (Million USD) and Growth Rate (2017-2025)
Figure Italy Gastrointestinal Therapeutics Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Europe Gastrointestinal Therapeutics Revenue (Million USD) and Growth Rate (2017-2025)
Figure China Gastrointestinal Therapeutics Revenue (Million USD) and Growth Rate (2017-2025)
Figure Japan Gastrointestinal Therapeutics Revenue (Million USD) and Growth Rate (2017-2025)
Figure Korea Gastrointestinal Therapeutics Revenue (Million USD) and Growth Rate (2017-2025)
Figure India Gastrointestinal Therapeutics Revenue (Million USD) and Growth Rate (2017-2025)
Figure Southeast Asia Gastrointestinal Therapeutics Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Asia-Pacific Gastrointestinal Therapeutics Revenue (Million USD) and Growth Rate (2017-2025)
Figure Brazil Gastrointestinal Therapeutics Revenue (Million USD) and Growth Rate (2017-2025)
Figure Argentina Gastrointestinal Therapeutics Revenue (Million USD) and Growth Rate (2017-2025)
Figure Columbia Gastrointestinal Therapeutics Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of South America Gastrointestinal Therapeutics Revenue (Million USD) and Growth Rate (2017-2025)
Figure Saudi Arabia Gastrointestinal Therapeutics Revenue (Million USD) and Growth Rate (2017-2025)
Figure United Arab Emirates Gastrointestinal Therapeutics Revenue (Million USD) and Growth Rate (2017-2025)
Figure Egypt Gastrointestinal Therapeutics Revenue (Million USD) and Growth Rate (2017-2025)
Figure Nigeria Gastrointestinal Therapeutics Revenue (Million USD) and Growth Rate (2017-2025)
Figure South Africa Gastrointestinal Therapeutics Revenue (Million USD) and Growth Rate (2017-2025)
Figure Turkey Gastrointestinal Therapeutics Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Middle East and Africa Gastrointestinal Therapeutics Revenue (Million USD) and Growth Rate (2017-2025)
Table Global Gastrointestinal Therapeutics Revenue and Revenue Share by Route (2017-2018)
Figure Global Oral Revenue and Growth Rate (2017-2018)
Figure Global Intravenous Revenue and Growth Rate (2017-2018)
Figure Global Others Revenue and Growth Rate (2017-2018)
Table Global Gastrointestinal Therapeutics Revenue and Revenue Share by Application (2017-2018)
Figure Global Ulcerative Colitis Revenue and Growth Rate (2017-2018)
Figure Global Crohn’s Disease Revenue and Growth Rate (2017-2018)
Figure Global GERD Revenue and Growth Rate (2017-2018)
Figure Global Other Application Revenue and Growth Rate (2017-2018)
Table Global Gastrointestinal Therapeutics Revenue by Regions (2017-2018)
Figure North America Gastrointestinal Therapeutics Growth Rate (2017-2018)
Figure North America Gastrointestinal Therapeutics Revenue and Growth Rate (2017-2018)
Figure North America Gastrointestinal Therapeutics by Countries (2017-2018)
Figure North America Gastrointestinal Therapeutics Revenue (Million USD) by Countries (2017-2018)
Figure United States Gastrointestinal Therapeutics Growth Rate (2017-2018)
Figure United States Gastrointestinal Therapeutics Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Canada Gastrointestinal Therapeutics Growth Rate (2017-2018)
Figure Canada Gastrointestinal Therapeutics Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Mexico Gastrointestinal Therapeutics Growth Rate (2017-2018)
Figure Mexico Gastrointestinal Therapeutics Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Europe Gastrointestinal Therapeutics Growth Rate (2017-2018)
Figure Europe Gastrointestinal Therapeutics Revenue and Growth Rate (2017-2018)
Figure Europe Gastrointestinal Therapeutics by Countries (2017-2018)
Figure Europe Gastrointestinal Therapeutics Revenue (Million USD) by Countries (2017-2018)
Figure Germany Gastrointestinal Therapeutics Growth Rate (2017-2018)
Figure Germany Gastrointestinal Therapeutics Revenue (Millions USD) and Growth Rate (2017-2018)
Figure France Gastrointestinal Therapeutics Growth Rate (2017-2018)
Figure France Gastrointestinal Therapeutics Revenue (Millions USD) and Growth Rate (2017-2018)
Figure UK Gastrointestinal Therapeutics Growth Rate (2017-2018)
Figure UK Gastrointestinal Therapeutics Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Russia Gastrointestinal Therapeutics Growth Rate (2017-2018)
Figure Russia Gastrointestinal Therapeutics Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Italy Gastrointestinal Therapeutics Growth Rate (2017-2018)
Figure Italy Gastrointestinal Therapeutics Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Europe Gastrointestinal Therapeutics Growth Rate (2017-2018)
Figure Rest of Europe Gastrointestinal Therapeutics Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Asia-Pacific Gastrointestinal Therapeutics Growth Rate (2017-2018)
Figure Asia-Pacific Gastrointestinal Therapeutics Revenue and Growth Rate (2017-2018)
Figure Asia-Pacific Gastrointestinal Therapeutics by Countries (2017-2018)
Figure Asia-Pacific Gastrointestinal Therapeutics Revenue (Million USD) by Countries (2017-2018)
Figure China Gastrointestinal Therapeutics Growth Rate (2017-2018)
Figure China Gastrointestinal Therapeutics Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Japan Gastrointestinal Therapeutics Growth Rate (2017-2018)
Figure Japan Gastrointestinal Therapeutics Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Korea Gastrointestinal Therapeutics Growth Rate (2017-2018)
Figure Korea Gastrointestinal Therapeutics Revenue (Millions USD) and Growth Rate (2017-2018)
Figure India Gastrointestinal Therapeutics Growth Rate (2017-2018)
Figure India Gastrointestinal Therapeutics Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Southeast Asia Gastrointestinal Therapeutics Growth Rate (2017-2018)
Figure Southeast Asia Gastrointestinal Therapeutics Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Asia-Pacific Gastrointestinal Therapeutics Growth Rate (2017-2018)
Figure Rest of Asia-Pacific Gastrointestinal Therapeutics Revenue (Millions USD) and Growth Rate (2017-2018)
Figure South America Gastrointestinal Therapeutics Growth Rate (2017-2018)
Figure South America Gastrointestinal Therapeutics Revenue and Growth Rate (2017-2018)
Figure South America Gastrointestinal Therapeutics by Countries (2017-2018)
Figure South America Gastrointestinal Therapeutics Revenue (Million USD) by Countries (2017-2018)
Figure Brazil Gastrointestinal Therapeutics Growth Rate (2017-2018)
Figure Brazil Gastrointestinal Therapeutics Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Argentina Gastrointestinal Therapeutics Growth Rate (2017-2018)
Figure Argentina Gastrointestinal Therapeutics Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Columbia Gastrointestinal Therapeutics Growth Rate (2017-2018)
Figure Columbia Gastrointestinal Therapeutics Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of South America Gastrointestinal Therapeutics Growth Rate (2017-2018)
Figure Rest of South America Gastrointestinal Therapeutics Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Middle East and Africa Gastrointestinal Therapeutics Growth Rate (2017-2018)
Figure Middle East and Africa Gastrointestinal Therapeutics Revenue and Growth Rate (2017-2018)
Figure Middle East and Africa Gastrointestinal Therapeutics by Countries (2017-2018)
Figure Middle East and Africa Gastrointestinal Therapeutics Revenue (Million USD) by Countries (2017-2018)
Figure Saudi Arabia Gastrointestinal Therapeutics Growth Rate (2017-2018)
Figure Saudi Arabia Gastrointestinal Therapeutics Revenue (Millions USD) and Growth Rate (2017-2018)
Figure United Arab Emirates Gastrointestinal Therapeutics Growth Rate (2017-2018)
Figure United Arab Emirates Gastrointestinal Therapeutics Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Egypt Gastrointestinal Therapeutics Growth Rate (2017-2018)
Figure Egypt Gastrointestinal Therapeutics Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Nigeria Gastrointestinal Therapeutics Growth Rate (2017-2018)
Figure Nigeria Gastrointestinal Therapeutics Revenue (Millions USD) and Growth Rate (2017-2018)
Figure South Africa Gastrointestinal Therapeutics Growth Rate (2017-2018)
Figure South Africa Gastrointestinal Therapeutics Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Turkey Gastrointestinal Therapeutics Growth Rate (2017-2018)
Figure Turkey Gastrointestinal Therapeutics Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Middle East and Africa Gastrointestinal Therapeutics Growth Rate (2017-2018)
Figure Rest of Middle East and Africa Gastrointestinal Therapeutics Revenue (Millions USD) and Growth Rate (2017-2018)
Table Allergan plc Gastrointestinal Therapeutics Financial Overview
Table Boehringer Ingelheim GmbH Gastrointestinal Therapeutics Financial Overview
Table AstraZeneca PLC Gastrointestinal Therapeutics Financial Overview
Table Valeant Pharmaceuticals International company Gastrointestinal Therapeutics Financial Overview
Table Abbott Laboratories Gastrointestinal Therapeutics Financial Overview
Table Takeda Pharmaceutical Company Limited Gastrointestinal Therapeutics Financial Overview
Table Janssen Biotech, Inc. Gastrointestinal Therapeutics Financial Overview
Table Sanofi company Gastrointestinal Therapeutics Financial Overview
Table Bayer AG Gastrointestinal Therapeutics Financial Overview
Table GlaxoSmithKline plc Gastrointestinal Therapeutics Financial Overview
Figure Global Gastrointestinal Therapeutics Revenue (Millions USD) and Growth Rate (2018-2025)
Table Gastrointestinal Therapeutics Market Forecast by Regions (2018-2025)
Figure North America Gastrointestinal Therapeutics Market Forecast (2018-2025)
Figure United States Gastrointestinal Therapeutics Market Forecast (2018-2025)
Figure Canada Gastrointestinal Therapeutics Market Forecast (2018-2025)
Figure Mexico Gastrointestinal Therapeutics Market Forecast (2018-2025)
Figure Europe Gastrointestinal Therapeutics Market Forecast (2018-2025)
Figure Germany Gastrointestinal Therapeutics Market Forecast (2018-2025)
Figure France Gastrointestinal Therapeutics Market Forecast (2018-2025)
Figure UK Gastrointestinal Therapeutics Market Forecast (2018-2025)
Figure Russia Gastrointestinal Therapeutics Market Forecast (2018-2025)
Figure Italy Gastrointestinal Therapeutics Market Forecast (2018-2025)
Figure Rest of Europe Gastrointestinal Therapeutics Market Forecast (2018-2025)
Figure Asia-Pacific Gastrointestinal Therapeutics Market Forecast (2018-2025)
Figure China Gastrointestinal Therapeutics Market Forecast (2018-2025)
Figure Japan Gastrointestinal Therapeutics Market Forecast (2018-2025)
Figure Korea Gastrointestinal Therapeutics Market Forecast (2018-2025)
Figure India Gastrointestinal Therapeutics Market Forecast (2018-2025)
Figure Southeast Asia Gastrointestinal Therapeutics Market Forecast (2018-2025)
Figure Rest of Asia-Pacific Gastrointestinal Therapeutics Market Forecast (2018-2025)
Figure South America Gastrointestinal Therapeutics Market Forecast (2018-2025)
Figure Brazil Gastrointestinal Therapeutics Market Forecast (2018-2025)
Figure Argentina Gastrointestinal Therapeutics Market Forecast (2018-2025)
Figure Columbia Gastrointestinal Therapeutics Market Forecast (2018-2025)
Figure Rest of South America Gastrointestinal Therapeutics Market Forecast (2018-2025)
Figure Middle East and Africa Gastrointestinal Therapeutics Market Forecast (2018-2025)
Figure Saudi Arabia Gastrointestinal Therapeutics Market Forecast (2018-2025)
Figure United Arab Emirates Gastrointestinal Therapeutics Market Forecast (2018-2025)
Figure Egypt Gastrointestinal Therapeutics Market Forecast (2018-2025)
Figure Nigeria Gastrointestinal Therapeutics Market Forecast (2018-2025)
Figure South Africa Gastrointestinal Therapeutics Market Forecast (2018-2025)
Figure Turkey Gastrointestinal Therapeutics Market Forecast (2018-2025)
Figure Rest of Middle East and Africa Gastrointestinal Therapeutics Market Forecast (2018-2025)
Figure Global Gastrointestinal Therapeutics Forecast by Route (2018-2025)
Figure Global Gastrointestinal Therapeutics Market Share Forecast by Route (2018-2025)
Figure Global Gastrointestinal Therapeutics Forecast by Route (2018-2025)
Figure Global Gastrointestinal Therapeutics Forecast by Application (2018-2025)
Figure Global Gastrointestinal Therapeutics Market Share Forecast by Application (2018-2025)
Figure Global Gastrointestinal Therapeutics Forecast by Application (2018-2025)
Please Note: Data related to the Companies are subject to Availability.
Research Methodology
We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.
Data Mining
Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.
Data Collection Matrix
|
Data Collection Matrix |
Supply Side |
Demand Side |
|
Primary Data Sources |
|
|
|
Secondary Data Sources |
|
|
Market Modeling and Forecasting
We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.
- Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
- Number of patients for particular device or medical procedure and
- Repeated use of particular device depending on health and condition of patient
- Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.
We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.
Data Validation
We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.
Data Triangulation
Industry Analysis
|
Qualitative Data |
Quantitative Data (2017-2025) |
|
|